These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 15125499)

  • 41. In vitro antimicrobial activity of benzoyl peroxide against Propionibacterium acnes assessed by a novel susceptibility testing method.
    Okamoto K; Ikeda F; Kanayama S; Nakajima A; Matsumoto T; Ishii R; Umehara M; Gotoh N; Hayashi N; Iyoda T; Matsuzaki K; Matsumoto S; Kawashima M
    J Infect Chemother; 2016 Jun; 22(6):426-9. PubMed ID: 26806150
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Acne and Propionibacterium acnes.
    Bojar RA; Holland KT
    Clin Dermatol; 2004; 22(5):375-9. PubMed ID: 15556721
    [TBL] [Abstract][Full Text] [Related]  

  • 43. SIG1273: a new cosmetic functional ingredient to reduce blemishes and Propionibacterium acnes in acne prone skin.
    Fernandéz JR; Rouzard K; Voronkov M; Feng X; Stock JB; Stock M; Gordon JS; Shroot B; Christensen MS; Pérez E
    J Cosmet Dermatol; 2012 Dec; 11(4):272-8. PubMed ID: 23174050
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Topical Minocycline Foam 4%: A Review in Acne Vulgaris.
    Paik J
    Am J Clin Dermatol; 2020 Jun; 21(3):449-456. PubMed ID: 32468355
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro activities of azole antifungal agents against Propionibacterium acnes isolated from patients with acne vulgaris.
    Sugita T; Miyamoto M; Tsuboi R; Takatori K; Ikeda R; Nishikawa A
    Biol Pharm Bull; 2010; 33(1):125-7. PubMed ID: 20045949
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Propionibacterium acnes lipase in seborrheic dermatitis and other skin diseases and Unsei-in.
    Higaki S; Morohashi M
    Drugs Exp Clin Res; 2003; 29(4):157-9. PubMed ID: 15018307
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [A comparison of biochemical and genetic classification of propionibacterium acnes strains isolated from skin lesions of patients with acne].
    Kasprowicz A; Owczarek MM; Miedzobrodzki J; Białecka A
    Med Dosw Mikrobiol; 2012; 64(3):203-10. PubMed ID: 23285774
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tetracycline-resistant propionibacteria from acne patients are cross-resistant to doxycycline, but sensitive to minocycline.
    Eady EA; Jones CE; Gardner KJ; Taylor JP; Cove JH; Cunliffe WJ
    Br J Dermatol; 1993 May; 128(5):556-60. PubMed ID: 8504049
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of lipase activity in antibiotic-resistant propionibacterium acnes strains.
    Gloor M; Wasik B; Becker A; Höffler U
    Dermatology; 2002; 205(3):260-4. PubMed ID: 12399674
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adult acne in women is not associated with a specific type of Cutibacterium acnes.
    Saint-Jean M; Corvec S; Nguyen JM; Le Moigne M; Boisrobert A; Khammari A; Dréno B
    J Am Acad Dermatol; 2019 Sep; 81(3):851-852. PubMed ID: 30905801
    [No Abstract]   [Full Text] [Related]  

  • 51. Hop Extract Acts as an Antioxidant with Antimicrobial Effects against
    Weber N; Biehler K; Schwabe K; Haarhaus B; Quirin KW; Frank U; Schempp CM; Wölfle U
    Molecules; 2019 Jan; 24(2):. PubMed ID: 30634461
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antibiotic resistance of microbial strains isolated from Korean acne patients.
    Moon SH; Roh HS; Kim YH; Kim JE; Ko JY; Ro YS
    J Dermatol; 2012 Oct; 39(10):833-7. PubMed ID: 22779738
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Typing of Propionibacterium acnes: a review of methods and comparative analysis.
    Yu Y; Champer J; Garbán H; Kim J
    Br J Dermatol; 2015; 172(5):1204-9. PubMed ID: 25600912
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of subminimal inhibitory concentrations of minocycline on neutrophil chemotactic factor production in comedonal bacteria, neutrophil phagocytosis and oxygen metabolism.
    Akamatsu H; Niwa Y; Kurokawa I; Masuda R; Nishijima S; Asada Y
    Arch Dermatol Res; 1991; 283(8):524-8. PubMed ID: 1838472
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rhodomyrtone inhibits lipase production, biofilm formation, and disorganizes established biofilm in Propionibacterium acnes.
    Wunnoo S; Saising J; Voravuthikunchai SP
    Anaerobe; 2017 Feb; 43():61-68. PubMed ID: 27923605
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transconjugation of erm(X) conferring high-level resistance of clindamycin for Cutibacterium acnes.
    Aoki S; Nakase K; Hayashi N; Noguchi N
    J Med Microbiol; 2019 Jan; 68(1):26-30. PubMed ID: 30431414
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Propionibacterium acnes is developing gradual increase in resistance to oral tetracyclines.
    Nakase K; Nakaminami H; Takenaka Y; Hayashi N; Kawashima M; Noguchi N
    J Med Microbiol; 2017 Jan; 66(1):8-12. PubMed ID: 28218057
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antibiotic resistance in the topical treatment of acne vulgaris.
    Leyden JJ
    Cutis; 2004 Jun; 73(6 Suppl):6-10. PubMed ID: 15228128
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multicenter cross-sectional observational study of antibiotic resistance and the genotypes of Propionibacterium acnes isolated from Chinese patients with acne vulgaris.
    Fan Y; Hao F; Wang W; Lu Y; He L; Wang G; Chen W
    J Dermatol; 2016 Apr; 43(4):406-13. PubMed ID: 26508505
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Propionibacterium acnes, an emerging pathogen: from acne to implant-infections, from phylotype to resistance.
    Aubin GG; Portillo ME; Trampuz A; Corvec S
    Med Mal Infect; 2014 Jun; 44(6):241-50. PubMed ID: 24656842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.